Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 1.

Table. 1.

Clinical characteristics by lymphopenia

Variable No lymphopenia n=80 (%) Persistent lymphopenia n=81 (%) p value
Age, median (years) [range] 65 [25-92] 67 [23-85] 0.156
Male sex 37 (46.3) 51 (63.0) 0.033
Charlson-Deyo Score, median [range] 4 [0-9] 4 [0-9] 0.753
Pre-operative lymphopenia 1 (2) 10 (17.2) 0.009
POD#3 leukocytosis 43 (53.8) 38 (46.9) 0.386
Neo-adjuvant therapy 4 (5) 5 (6.2) 0.746
Pre-operative stenting/drainage procedure 23 (28.75) 22 (27.2) 0.822
Tumor type 0.122
Pancreatic adenocarcinoma 54 (66.7) 41 (50.6)
Peri-ampullary/ampullary adenocarcinoma 13 (16.3) 15 (18.5)
IPMN 3 (3.75) 11 (13.6)
Inflammatory 2 (2.5) 2 (2.5)
Other 8 (10) 12 (14.8)
Vascular resection 7 (8.8) 9 (11.1) 0.617
Lymphovascular invasion 37 (46.3) 41 (50.6) 0.579
Perineural invasion 48 (60) 52 (64.2) 0.583
Intraoperative Transfusion 8 (10.7) 14 (18.4) 0.177
Pancreatic duct diameter (mm), median [range] 5 [1.5-10] 4 [2-15] 0.594
Gland texture 0.837
Soft 1 (50) 3 (33.3)
Intermediate 0 (0) 1 (11.1)
Firm 1 (50) 5 (55.6)
Ann Hepatobiliary Pancreat Surg 2021;25:242-50 https://doi.org/10.14701/ahbps.2021.25.2.242
© 2021 Ann Hepatobiliary Pancreat Surg